Quest Diagnostics | DGX - Cash And Equivalent

Stock Price
192.30
Daily Change
3.07 1.62%
Monthly
6.56%
Yearly
18.24%
Q1 Forecast
181.27

Quest Diagnostics reported $432M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Acadia Healthcare USD 118.69M 12.73M Sep/2025
Agilent USD 1.79B 254M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Centene USD 17.06B 2.55B Sep/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Cigna USD 6.02B 1.7B Sep/2025
CVS Health USD 9.1B 2.69B Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
DaVita Healthcare Partners USD 705.96M 2.46M Sep/2025
Elevance Health USD 9.49B 778M Dec/2025
Encompass Health USD 72.2M 23.5M Dec/2025
HCA USD 1.04B 43M Dec/2025
Henry Schein USD 136M 9M Sep/2025
Humana USD 5.39B 1.35B Sep/2025
Illumina USD 1.42B 368M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
McKesson USD 2.96B 1.05B Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Molina Healthcare USD 4.25B 27M Dec/2025
Owens Minor USD 32.84M 5.42M Sep/2025
Quest Diagnostics USD 432M 113M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Tenet Healthcare USD 2.98B 350M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
UnitedHealth USD 28.12B 2.49B Dec/2025
Universal Health Services USD 112.9M 24.7M Sep/2025
Waters USD 459.12M 91.9M Sep/2025
Zoetis USD 2.08B 649M Sep/2025